药物治疗多药耐药性格拉姆阳性感染的药物治疗方法:当前的选择和以后的选择
Sebastiano Leone1, Ilaria Pezone2, Mariantonietta Pisaturo3
1Division of Infectious Diseases, "San Giuseppe Moscati" Hospital, Avellino, Italy.
Expert opinion on pharmacotherapy
|June 12, 2024
概括
多种耐药生物体 (MDRO) 感染对公众健康构成重大威胁. 本综述考察了当前和正在开发的格拉姆阳性MDROs的治疗方法,强调组合疗法.
科学领域:
- 传染性疾病 传染性疾病
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 耐多药生物体 (MDROs) 构成了全球卫生面临的重大挑战,其特点是疾病和死亡率高.
- 尽管有众多抗生素可用,但对格拉姆阳性MDRO感染的最佳治疗策略仍然是一个重大问题.
研究的目的:
- 审查当前的治疗方案,对格拉姆阳性MDRO感染.
- 探索新兴的非传统抗菌剂及其在治疗中的潜在作用.
主要方法:
- 在PubMed/Medline数据库上进行了全面的文献搜索.
- 搜索没有语言或时间限制.
- 该审查综合了关于既有和新型抗菌方法的发现.
主要成果:
- 葡萄糖仍然是格拉姆阳性感染的主要治疗方法,在新的抗生素试验中作为基准.
- 非葡萄糖治疗的证据主要来自后期分析和元分析.
- 非传统的抗菌剂正在研究,以加强短期和有效的抗生素治疗方案.
结论:
- 葡萄糖继续是格拉姆阳性MDRO感染管理的基石.
- 非传统的抗菌剂显示出有前途,特别是当与现有的抗生素疗法一起使用时.
- 进一步研究组合策略对于对抗耐药性感染至关重要.
相关概念视频
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Pneumonia IV: Management
322
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
322
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
363
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
363
Pulmonary Tuberculosis V
177
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
177
Antibiotic Selection
53.1K
Overview
53.1K
Peptic Ulcer Disease IV: Management
87
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
87


